Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 302 followers
Latest posts
Last updated about 10 hours ago
Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts
about 10 hours ago
Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after its other...
Elon Musk to step down from DOGE leadership role: Politico
about 11 hours ago
In the upcoming weeks, Tesla CEO Elon Musk is expected to step...
‘Patently illegal’: NIH and HHS face new lawsuit over $1.1B in revoked research grants
about 12 hours ago
The American Public Health Association and several researchers are suing the NIH...
British biotech CellCentric expands to Boston with plans to grow into late-stage clinical development
about 13 hours ago
British biotech CellCentric is settling into a new office in Boston, part...
Princeton and Harvard join other Ivy League schools facing funding cuts, putting research at risk
about 13 hours ago
The Trump administration is halting research funding to Princeton University and reviewing...
Medtronic inks stroke AI partnership with European developer Methinks
about 15 hours ago
The medtech giant plans to integrate Methinks AI’s apps with its portfolio...
CMR Surgical nets $200M to support Versius robot’s US launch
about 15 hours ago
Following the FDA clearance of its Versius robot last fall, CMR Surgical...
FDA’s Chief Medical Officer Hilary Marston is out mid mass layoffs
about 16 hours ago
The FDA’s Chief Medical Officer Hilary Marston, M.D., is leaving her position...
Edgewise claims heart valve pressure benefits in phase 2 trial for potential Camzyos rival
about 18 hours ago
Edgewise Therapeutics' hypertrophic cardiomyopathy asset has resulted in “rapid and clinically meaningful”...
Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M
about 18 hours ago
Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15...
Atsena raises $150M for ocular gene therapies with Bain, Sofinnova in tow
about 19 hours ago
Atsena Therapeutics has raised $150 million in an oversubscribed series C financing...
Patient suffers side effect in Cabaletta autoimmune CAR-T trial, but analysts unfazed
about 20 hours ago
Analysts appeared unfazed by the news that a patient treated with Cabaletta...